Document is current
Any future updates will be listed below
-
Authors
Pan, Cassie
Ng, Kevin
Voutsinas, Jenna
Barber, Brittany
Rizvi, Zain H.
Marchiano, Emily
Ferrandino, Rocco M.
Futran, Neal
Laramore, George E.
Liao, Jay J.
Parvathaneni, Upendra
Panjwani, Neil
Martins, Renato G.
Rodriguez, Cristina P.
Wu, Qian “Vicky”
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32 DC000018)
- License Information
-
More Information
Article History
Received: 23 June 2024
Accepted: 9 October 2024
First Online: 15 November 2024
Declarations
:
: This study was reviewed and approved by the Fred Hutchinson Cancer Research Institutional Review Board (IRB ID: STUDY00007717). The requirement to obtain informed consent was waived.
: Not applicable.
: Conflict of Interest Disclosures: Dr. Futran reported educational consultancy role for Stryker Corporation. Dr. Rodriguez reported receipt of institutional research funding from AstraZeneca, Ayala, Bristol Myers Squibb, Ignyta, and Merck, and reported advisory board membership for Cue Biopharma. The other authors declare no potential conflicts of interest.
